Advanced search
Publication Cover
Hematology Volume 22, 2017 - Issue 6
Submit an article Journal homepage
1,370
Views
11
CrossRef citations to date
0
Altmetric
Myeloproliferative Disease

CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia

Shin-ichiro FujiwaraDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, JapanCorrespondence[email protected]
View further author information
,
Kazuo MuroiDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, Japan;Division of Cell Transplantation and Transfusion, Jichi Medical University, Tochigi, JapanView further author information
,
Chihiro YamamotoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, JapanView further author information
,
Kaoru HatanoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, JapanView further author information
,
Kiyoshi OkazukaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, JapanView further author information
,
Kazuya SatoDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, JapanView further author information
,
Iekuni OhDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, JapanView further author information
,
Ken OhmineDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, JapanView further author information
,
Takahiro SuzukiDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, JapanView further author information
&
Keiya OzawaDivision of Hematology, Department of Medicine, Jichi Medical University, Tochigi, JapanView further author information
 show all
Pages 347-353 | Published online: 18 Jan 2017

References

  • Thein MS, Ershler WB, Jemal A, et al. Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades. Cancer. 2013;119(15):2720–2727. doi: 10.1002/cncr.28129
  • Klepin HD, Rao AV, Pardee TS. Acute myeloid leukemia and myelodysplastic syndromes in older adults. J Clin Oncol. 2014;32(24):2541–2552. doi: 10.1200/JCO.2014.55.1564
  • Nazha A, Ravandi F. Acute myeloid leukemia in the elderly: do we know who should be treated and how?. Leuk Lymphoma. 2014;55(5):979–987. doi: 10.3109/10428194.2013.828348
  • Yanada M, Naoe T. Acute myeloid leukemia in older adults. Int J Hematol. 2012;96(2):186–193. doi: 10.1007/s12185-012-1137-3
  • Olejniczak K, Kasprzak A. Biological properties of interleukin 2 and its role in pathogenesis of selected diseases--a review. Med Sci Monit. 2008;14(10):Ra179–Ra189.
  • Kuhn DJ, Dou QP. The role of interleukin-2 receptor alpha in cancer. Front Biosci. 2005;10:1462–1464. doi: 10.2741/1631
  • Saito Y, Kitamura H, Hijikata A, et al. Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Sci Transl Med. 2010;2(17):170ra9. doi: 10.1126/scitranslmed.3000349
  • Gonen M, Sun Z, Figueroa ME, et al. CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900. Blood. 2012;120(11):2297–2306. doi: 10.1182/blood-2012-02-414425
  • Terwijn M, Feller N, van Rhenen A, et al. Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML. Eur J Cancer. 2009;45(9):1692–1699. doi: 10.1016/j.ejca.2009.02.021
  • Cerny J, Yu H, Ramanathan M, et al. Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia (AML). Br J Haematol. 2013;160(2):262–266. doi: 10.1111/bjh.12109
  • Nakase K, Kita K, Kyo T, et al. Prognostic Relevance of cytokine receptor expression in acute myeloid leukemia: interleukin-2 receptor alpha-chain (CD25) expression predicts a poor prognosis. PLoS One. 2015;10(9):e0128998. doi: 10.1371/journal.pone.0128998
  • Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood. 1998;92(7):2322–2333.
  • Yamada K, Furusawa S, Saito K, et al. Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: a pilot study. Leukemia. 1995;9(1):10–14.
  • Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol. 2003;21(24):4642–4649. doi: 10.1200/JCO.2003.04.036
  • Miltiades P, Lamprianidou E, Vassilakopoulos TP, et al. Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine. Blood Cancer J. 2014;4:e187. doi: 10.1038/bcj.2014.9
  • Ikegawa S, Doki N, Yamamoto K, et al. Clinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia. Leuk Lymphoma. 2015;56(6):1874–1877. doi: 10.3109/10428194.2014.974044
  • Koreth J, Aldridge J, Kim HT, et al. Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age. Biol Blood Marrow Transplant. 2010;16(6):792–800. doi: 10.1016/j.bbmt.2009.12.537

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.